Issue 3/2016
Content (25 Articles)
Primary pituitary lymphoma: an update of the literature
A. Tarabay, G. Cossu, M. Berhouma, M. Levivier, R. T. Daniel, M. Messerer
Reevaluating stereotactic radiosurgery for glioblastoma: new potential for targeted dose-escalation
Ted K. Yanagihara, Heva J. Saadatmand, Tony J. C. Wang
Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients
Tal Shahar, Avital Granit, Daniel Zrihan, Tamar Canello, Hanna Charbit, Ofira Einstein, Uri Rozovski, Sharona Elgavish, Zvi Ram, Tali Siegal, Iris Lavon
Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas
Kavneet Kaur, Aanchal Kakkar, Anupam Kumar, Suvendu Purkait, Supriya Mallick, Vaishali Suri, Mehar C. Sharma, Pramod K. Julka, Deepak Gupta, Ashish Suri, Chitra Sarkar
Changes in PlGF and MET-HGF expressions in paired initial and recurrent glioblastoma
Emeline Tabouret, Emilie Denicolai, Christine Delfino, Thomas Graillon, Celine Boucard, Isabelle Nanni, Laetitia Padovani, Dominique Figarella-Branger, Olivier Chinot
Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients
Charlotte Aaberg-Jessen, Bo Halle, Stine S. Jensen, Sven Müller, Unni Maria Rømer, Christian B. Pedersen, Nils Brünner, Bjarne W. Kristensen
Safety, feasibility, and optimization of intra-arterial mitoxantrone delivery to gliomas
Jason A. Ellis, Johann Cooke, Rajinder P. Singh-Moon, Mei Wang, Jeffrey N. Bruce, Charles W. Emala, Irving J. Bigio, Shailendra Joshi
OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells
Malek Hossein Asadi, Khosrow Khalifeh, Seyed Javad Mowla
Topiramate induces acute intracellular acidification in glioblastoma
Kamini Marathe, Nevin McVicar, Alex Li, Miranda Bellyou, Susan Meakin, Robert Bartha
Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas
M. Bujko, P. Kober, N. Rusetska, M. Wakuła, K. Goryca, E. Grecka, E. Matyja, J. Neska, T. Mandat, W. Bonicki, J. A. Siedlecki
Time-delayed contrast-enhanced MRI improves detection of brain metastases: a prospective validation of diagnostic yield
Or Cohen-Inbar, Zhiyuan Xu, Blair Dodson, Tanvir Rizvi, Christopher R. Durst, Sugoto Mukherjee, Jason P. Sheehan
Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma
Allison F. O’Neill, Lei Qin, Patrick Y. Wen, John F. de Groot, Annick D. Van den Abbeele, Jeffrey T. Yap
Occupational exposure to metals and risk of meningioma: a multinational case-control study
Siegal Sadetzki, Angela Chetrit, Michelle C. Turner, Martie van Tongeren, Geza Benke, Jordi Figuerola, Sarah Fleming, Martine Hours, Laurel Kincl, Daniel Krewski, Dave McLean, Marie-Elise Parent, Lesley Richardson, Brigitte Schlehofer, Klaus Schlaefer, Maria Blettner, Joachim Schüz, Jack Siemiatycki, Elisabeth Cardis
Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study
Ian F. Pollack, Regina I. Jakacki, Lisa H. Butterfield, Ronald L. Hamilton, Ashok Panigrahy, Daniel P. Normolle, Angela K. Connelly, Sharon Dibridge, Gary Mason, Theresa L. Whiteside, Hideho Okada
Molecular and histologic characteristics of pseudoprogression in diffuse gliomas
Andrew L. Lin, Michael White, Michelle M. Miller-Thomas, Robert S. Fulton, Christina I. Tsien, Keith M. Rich, Robert E. Schmidt, David D. Tran, Sonika Dahiya
Surgical management of posterior fossa metastases
Geraint J. Sunderland, Michael D. Jenkinson, Rasheed Zakaria
Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma
Seunggu J. Han, Gerald Reis, Gary Kohanbash, Shruti Shrivastav, Stephen T. Magill, Annette M. Molinaro, Michael W. McDermott, Philip V. Theodosopoulos, Manish K. Aghi, Mitchel S. Berger, Nicholas A. Butowski, Igor Barani, Joanna J. Phillips, Arie Perry, Hideho Okada
Gamma Knife radiosurgery for neurofibromatosis type 2-associated meningiomas: a 22-year patient series
Brandon Birckhead, Terence T. Sio, Bruce E. Pollock, Michael J. Link, Nadia N. Laack
Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis
Nasser Alshehri, David J. Cote, M. Maher Hulou, Ahmad Alghamdi, Ali Alshahrani, Rania A. Mekary, Timothy R. Smith
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma
Edward Pan, Jeffrey G. Supko, Thomas J. Kaley, Nicholas A. Butowski, Timothy Cloughesy, Jinkyu Jung, Serena Desideri, Stuart Grossman, Xiaobu Ye, Deric M. Park
A case-matched study of stereotactic radiosurgery for patients with brain metastases: comparing treatment results for those with versus without neurological symptoms
Takao Koiso, Masaaki Yamamoto, Takuya Kawabe, Shinya Watanabe, Yasunori Sato, Yoshinori Higuchi, Tetsuya Yamamoto, Akira Matsumura, Hidetoshi Kasuya, Bierta E. Barfod
Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma
Oliver Schnell, Jun Thorsteinsdottir, Daniel Felix Fleischmann, Markus Lenski, Wolfgang Abenhardt, Armin Giese, Jörg-Christian Tonn, Claus Belka, Friedrich Wilhelm Kreth, Maximilian Niyazi
Long-term follow-up of a papillary tumor of the pineal region: addendum to a case report
Laura Lippa, Anna Maria Di Giacomo, Alfonso Cerase
Cerebellar dysfunction and spastic paraparesis associated to anti-Ri antibodies in a patient with a pancreatic neuroendocrine tumor
Abel Díaz Díaz, Miguel Hervás García, Ayoze González Hernández